日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity for Prediction of Postprophylaxis CMV Disease in a Phase 3 Trial of Letermovir Versus Valganciclovir Prophylaxis in Donor CMV-Seropositive/Recipient CMV-Seronegative Kidney Transplant Recipients

在供体 CMV 血清阳性/受体 CMV 血清阴性的肾移植受者中,来特莫韦与缬更昔洛韦预防治疗的 3 期试验中,巨细胞病毒 (CMV) 特异性细胞介导免疫用于预测预防后 CMV 疾病

Limaye, Ajit P; Crespo, Marta; Kamar, Nassim; Humar, Atul; Carroll, Robert P; Pereira, Marcus R; Broyde, Natalya; Wang, Weiwen; Haber, Barbara

Current and Future Strategies for the Prevention and Treatment of Cytomegalovirus Infections in Transplantation

移植中巨细胞病毒感染的预防和治疗的当前和未来策略

Heldman, Madeleine R; Boeckh, Michael J; Limaye, Ajit P

Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum

移植相关病毒感染论坛发布的《移植患者巨细胞病毒 (CMV) 感染和疾病(包括耐药和难治性 CMV)的共识定义(用于临床试验):2024 年更新》

Ljungman, Per; Chemaly, Roy F; Khawaya, Fareed; Alain, Sophie; Avery, Robin; Badshah, Cyrus; Boeckh, Michael; Fournier, Martha; Hodowanec, Aimee; Komatsu, Takashi; Limaye, Ajit P; Manuel, Oriol; Natori, Yoichiro; Navarro, David; Pikis, Andreas; Razonable, Raymund R; Westman, Gabriel; Miller, Veronica; Griffiths, Paul D; Kotton, Camille N

Association of Cytomegalovirus (CMV) DNAemia With Long-Term Mortality in a Randomized Trial of Preemptive Therapy and Antiviral Prophylaxis for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative Liver Transplant Recipients

巨细胞病毒(CMV)DNA血症与高危供体血清阳性、受体血清阴性肝移植受者中预防性治疗和抗病毒预防CMV疾病的长期死亡率的关联性随机试验

Kumar, Lakshin; Dasgupta, Sayan; Murray-Krezan, Cristina; Singh, Nina; Rakita, Robert M; Fisher, Cynthia E; Limaye, Ajit P

Response to Yates and Halliday Regarding Cytomegalovirus (CMV) DNAemia and Time to Death in a Randomized Trial of Preemptive Therapy Versus Antiviral Prophylaxis in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients

对 Yates 和 Halliday 关于巨细胞病毒 (CMV) DNA 血症和死亡时间的随机试验的回应,该试验比较了 CMV 供体血清阳性、受体血清阴性肝移植受者中先发制人治疗与抗病毒预防的效果。

Kumar, Lakshin; Dasgupta, Sayan; Murray-Krezan, Cristina; Singh, Nina; Rakita, Robert M; Fisher, Cynthia E; Limaye, Ajit P

How Immunocompromised Hosts Were Left Behind in the Quest to Control the COVID-19 Pandemic

在控制新冠疫情的努力中,免疫功能低下者是如何被忽视的?

Boeckh, Michael; Pergam, Steven A; Limaye, Ajit P; Englund, Janet; Corey, Lawrence; Hill, Joshua A

Cytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy versus prophylaxis

高危肝移植受者在接受先发制人抗病毒治疗与预防性治疗后巨细胞病毒免疫力的比较

Zamora, Danniel; Dasgupta, Sayan; Stevens-Ayers, Terry; Edmison, Bradley; Winston, Drew J; Razonable, Raymund R; Mehta, Aneesh K; Lyon, G Marshall; Boeckh, Michael; Singh, Nina; Koelle, David M; Limaye, Ajit P

Cytomegalovirus Viral Load Threshold to Guide Preemptive Therapy in Hematopoietic Cell Transplant Recipients: Correlation With Cytomegalovirus Disease

巨细胞病毒载量阈值指导造血干细胞移植受者预防性治疗:与巨细胞病毒疾病的相关性

Sadowska-Klasa, Alicja; Leisenring, Wendy M; Limaye, Ajit P; Boeckh, Michael

Evaluation of Three Cytomegalovirus IgG Lateral Flow Assays for Rapid Determination of CMV Serostatus

三种巨细胞病毒IgG侧向层析检测方法在快速确定CMV血清状态中的应用评价

Joncas-Schronce, Laurel; Ali, Fatima; Pepper, Gregory; Stapleton, Renee D; Rubenfeld, Gordon D; Boeckh, Michael; Limaye, Ajit P

Evaluation of the Tasso+ blood self-collection device for quantitation of plasma cytomegalovirus (CMV) DNAemia in adult solid organ transplant recipients (SOTr)

评估 Tasso+ 血液自采集装置在成人实体器官移植受者 (SOTr) 血浆巨细胞病毒 (CMV) DNA 血症定量中的应用

Phan, Tran; Kumar, Lakshin; Woo, Marissa; Sadowska-Klasa, Alicja; Castor, Jared; Pepper, Greg; Fisher, Cynthia E; Limaye, Ajit P